Dublin, Ohio-based Cardinal Health, Inc. (CAH) manufactures and distributes pharmaceuticals, medical & laboratory products, ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Healthcare distributor and services company Cardinal Health (NYSE:CAH) in Q4 CY2024, but sales fell by 3.8% year on year to $55.26 billion. Its non-GAAP profit of $1.93 per share was 9.4% above ...

Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Cardinal Health CEO Jason Hollar recounted the company's "nice run" at the nation's largest annual healthcare industry conference. Cardinal Health Inc. raised its earnings outlook for fiscal 2025 ...

Steven Valiquette; Analyst; Mizuho Financial Group ...

Cardinal said it might move production away ... defends its work 1:00 PM UTC · Updated ago Healthcare & Pharmaceuticalscategory No plan to prop up global health, Novo Nordisk Foundation says ...

Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.

Cardinal's forecast came ahead of a presentation at the JPMorgan Healthcare Conference, where the company is expected to provide more comments. Sign up here. President Donald Trump is likely to ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...